Trospium Chloride Tablet, Film Coated
Product Images NDC 72789-348

8 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 72789-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure diagram of trospium chloride showing its molecular components and bonds, including a quaternary ammonium ion with chloride counterion and bicyclic and diphenyl moieties.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A pharmacokinetic line graph showing plasma concentration of Trosium Chloride (ng/mL) on the vertical axis plotted against time in hours post-dose on the horizontal axis, spanning 0 to 48 hours. The graph depicts a concentration peak within the first few hours and a gradual decline over time, with error bars indicating variability at each time point.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph illustrating the mean change with standard error (SE) over weeks of treatment comparing TROSPIUM CHLORIDE tablets and placebo. The graph shows data points at weeks 1, 4, and 12, with statistically significant differences (p<0.001) favoring TROSPIUM CHLORIDE at weeks 4 and 12, and a near-significant difference (p=0.051) at week 1. The placebo group shows less change over time.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph showing mean (±SE) change over 12 weeks of treatment comparing placebo and Trospium Chloride tablets. The x-axis represents weeks of treatment (1, 4, and 12) and the y-axis shows mean change. Two data series are plotted: one for placebo (N=256) with a dotted line, and one for Trospium Chloride tablets (N=253) with a solid line, including p-values at weeks 4 and 12.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
Line graph comparing mean change over 12 weeks of treatment between placebo and Trosium Chloride 20 mg tablets in a clinical study. The y-axis shows mean (±SE) change. Trosium Chloride consistently shows a greater decrease than placebo across weeks 1, 4, and 12, with statistical significance indicated at each time point.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
A line graph comparing the mean change over weeks of treatment between patients taking Tropium Chloride tablets and those taking a placebo. The x-axis represents weeks of treatment (1, 4, 12), and the y-axis represents mean change with standard error. The Tropium Chloride group shows a greater decrease compared to placebo at all time points, with p-values less than 0.001.*
FDA Label Image

72789348 Label (72789348)

72789348 Label (72789348)
Label for Trospium Chloride 20 mg film-coated tablets, containing 60 tablets per container. The label displays the NDC 72789-348-60 and specifies that the product is Rx only. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Perrigo in Minneapolis, MN. The label includes storage instructions and a barcode.*
FDA Label Image

Serialization Template (Serialization Template)

Serialization Template (Serialization Template)
Label panel for TROSPIUM CHLORIDE 20 mg film-coated tablets showing placeholder text for serial number, lot number, and expiration date fields. The label indicates where these details should be inserted for product tracking and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.